The VPS35 gene and Parkinson's disease

Mov Disord. 2013 May;28(5):569-75. doi: 10.1002/mds.25430. Epub 2013 Mar 27.

Abstract

Parkinson's disease (PD), the second most common age-related neurodegenerative disease, is characterized by loss of dopaminergic and nondopaminergic neurons, leading to a variety of motor and nonmotor symptoms. In addition to environmental factors, genetic predisposition and specific gene mutations have been shown to play an important role in the pathogenesis of this disorder. Recently, the identification of the vacuolar protein sorting 35 homolog gene (VPS35), linked to autosomal dominant late-onset PD, has provided new clues to the pathogenesis of PD. Here we discuss the VPS35 gene, its protein function, and various pathways involved in Wnt/β-catenin signaling and in the role of DMT1 mediating the uptake of iron and iron translocation from endosomes to the cytoplasm. Further understanding of these mechanisms will undoubtedly provide new insights into the pathogenic mechanisms of PD and may lead to prevention and better treatment of the disorder.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Female
  • Genetic Predisposition to Disease*
  • Humans
  • Male
  • Mutation / genetics*
  • Parkinson Disease / genetics*
  • Transcription Factors / genetics
  • Vesicular Transport Proteins / genetics*

Substances

  • DMRT1 protein
  • Transcription Factors
  • VPS35 protein, human
  • Vesicular Transport Proteins